Exosens Stock Falls Over 2% and Ranks Among the Worst Declines of the SBF 120
The French specialist in night vision and imaging technology for defense is markedly down at midday, while the Paris stock market enjoys a breath of optimism. The stock is at the bottom of the SBF 120 after several already turbulent sessions. The technical setup is deteriorating in the short term.
Exosens in Sharp Decline While the SBF 120 Advances Nearly 1.8%
Exosens stock falls by 2.26% to €60.50, among the steepest declines of the SBF 120, even as the broader index gains 1.76% and the CAC 40 surges by 1.81%. The stock's downturn contrasts with the overall dynamics of a Parisian market boosted by Brent crude dipping below $90, following Donald Trump's mention of a possible peace deal in the Middle East.
The movement extends a turbulent sequence: Exosens has fallen by 3.43% over the week and 9.57% over three months, despite a solid annual performance still at +43%. Today's session follows on the heels of a failed rebound observed yesterday, already documented at midday, which did not allow the stock to sustainably recover.
The Stock Falls Below Its 20 and 50-Day Moving Averages, Indicating Short-Term Deterioration
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
You're in — subscription confirmed!
Your first edition is on its way. Check your spam folder and add us to your contacts.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours. L'essentiel des valeurs Euronext en quelques minutes.
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours
tendance · 6 séances
✓ C'est fait, vous êtes inscrit !
Votre première édition arrive bientôt. Pensez à vérifier vos spams.
Une erreur est survenue.
CAC 40 · SBF 120 · données indicatives · aucun conseil en investissement · désinscription à tout moment.
In terms of technical benchmarks, Exosens is now trading 4% below its MM20 at €63.02 and 4.3% below its MM50 at €63.24, two thresholds that had previously served as support since mid-May. The RSI at 48 remains neutral and does not indicate any excess, which leaves the door open for a continuation of the movement without immediate reversal signals. The underlying trend, however, remains bullish, with the price 12.6% above the MM200 at €53.74.
The support at €56.45 marks the next observation zone in case the decline continues. The medium-term dynamics are still driven by the group's recent industrial announcements, including the unveiling of a multi-sensor strategy for military tactical vision a few days ago and integration into the European SPIRIT project on infrared defense detection.
Nous avons constaté une forte croissance et une rentabilité.
Exosens continue de bénéficier d'une forte demande pour ses solutions de vision nocturne et d'imagerie numérique.
Risks mentioned
Tensions géopolitiques croissantes pourraient influencer la demande.
Risques liés à l'expansion des capacités de production.
Opportunities identified
Renforcement de la dynamique commerciale dans le marché de la défense.
Recours à des technologies optroniques avancées en pleine expansion.
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.
